Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.


Source: Cofisem - Last Update: 2025-03-18

Key Executives
Chief Executive Officer Carlo Rosa
Chief Financial Officer Piergiorgio Pedron
Chief Commercial Officer Chen Menachem Even
Chief Communication Officer Riccardo Fava
Head of Investor Relations Riccardo Fava
Director of Sustainable Development Riccardo Fava
Chief Human Resources Officer Stefano Ronchi


Source: Cofisem - Last Update: 2025-03-18

Key Figures
Millenium 2024 2023 2022 2021 2020
Net sales 1,185,000 1,148,210 1,361,138 1,237,654 881,305
Income from ordinary activities 1,185,000 1,148,210 1,361,138 1,237,654 881,305
Operating income 258,000 216,261 351,260 419,499 324,226
Cost of financial indebtedness net 28,291 34,072 22,506 1,375
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income 187,000 158,508 240,110 310,732 248,296
Net income (Group share) 159,849 240,907 310,968 247,871
Fiscal year end 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards IFRS IFRS IFRS IFRS IFRS

Source: Cofisem - Last Update: 2025-03-18

Shareholder information
Finde SS 44.96 %
Carlo Rosa 8.36 %
Chen Menachem Even 4.2 %
T. Rowe Price Associates, Inc. 3.03 %


Source: Cofisem - Last Update: 2025-03-18

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Diasorin